(KROS) Keros Therapeutics - Performance -75.9% in 12m
Compare KROS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-42.76%
#65 in Group
Rel. Strength
4.55%
#7595 in Universe
Total Return 12m
-75.93%
#150 in Group
Total Return 5y
-48.61%
#61 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: KROS (-75.9%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: KROS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KROS
| Total Return (including Dividends) | KROS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 43.65% | 11.81% | 13.81% |
| 3 Months | 33.65% | -13.61% | -6.30% |
| 12 Months | -75.93% | -12.29% | 10.65% |
| 5 Years | -48.61% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | KROS | XBI | S&P 500 |
| 1 Month | 63.0% | 72.9% | 83% |
| 3 Months | 63.8% | -83% | -75.3% |
| 12 Months | -58.3% | -51.6% | 50.1% |
| 5 Years | -16.8% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #8 | 28.5% | 26.2% |
| 3 Month | #11 | 54.7% | 42.6% |
| 12 Month | #150 | -72.6% | -78.2% |
| 5 Years | #63 | -31.6% | -75.3% |
FAQs
Does KROS Keros Therapeutics outperforms the market?
No,
over the last 12 months KROS made -75.93%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months KROS made 33.65%, while XBI made -13.61%.
Over the last 3 months KROS made 33.65%, while XBI made -13.61%.
Performance Comparison KROS vs Indeces and Sectors
KROS vs. Indices KROS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.95% | 29.8% | -74.4% | -86.6% |
| US NASDAQ 100 | QQQ | -5.14% | 26.3% | -74.6% | -87.6% |
| US Dow Jones Industrial 30 | DIA | -5.36% | 33.7% | -74.1% | -83.6% |
| German DAX 40 | DAX | -4.93% | 28.7% | -101% | -102% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.13% | 31.8% | -75.2% | -83.3% |
| Hongkong Hang Seng | HSI | -8.12% | 23.7% | -82.8% | -89.6% |
| India NIFTY 50 | INDA | -0.03% | 38.8% | -74.9% | -75.7% |
| Brasil Bovespa | EWZ | -6.0% | 26.4% | -83.1% | -67.6% |
KROS vs. Sectors KROS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.59% | 30.2% | -81.5% | -97.5% |
| Consumer Discretionary | XLY | -5.33% | 29.4% | -73.4% | -90.2% |
| Consumer Staples | XLP | -4.09% | 37.1% | -81.4% | -85.1% |
| Energy | XLE | -4.77% | 36.9% | -67.8% | -66.5% |
| Financial | XLF | -6.05% | 30.1% | -81.5% | -98.4% |
| Health Care | XLV | -1.94% | 42.8% | -69.4% | -71.9% |
| Industrial | XLI | -6.64% | 26.8% | -75.9% | -86.9% |
| Materials | XLB | -4.75% | 30.1% | -69.5% | -70.7% |
| Real Estate | XLRE | -3.63% | 32.1% | -75.2% | -91.4% |
| Technology | XLK | -6.03% | 22.4% | -71.5% | -83.0% |
| Utilities | XLU | -5.0% | 34.1% | -82.1% | -93.4% |
| Aerospace & Defense | XAR | -6.93% | 22.5% | -85.9% | -103% |
| Biotech | XBI | 1.64% | 31.8% | -54.3% | -63.6% |
| Homebuilder | XHB | -5.42% | 32.2% | -61.2% | -68.4% |
| Retail | XRT | -6.85% | 29.0% | -70.2% | -74.5% |